{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:11:51Z","timestamp":1782429111757,"version":"3.54.5"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Breast cancer (BC) patients diagnosed between two screenings (interval cancers) are more likely than screen-detected patients to carry rare deleterious mutations in cancer genes potentially leading to increased risk for other non-breast cancer (non-BC) tumors. In this study, we include 14,846 women diagnosed with BC of which 1,772 are interval and 13,074 screen-detected. Compared to\u00a0women with screen-detected cancers, interval breast cancer patients are more likely to have a non-BC tumor before (Odds ratio (OR): 1.43 [1.19\u20131.70], P\u2009=\u20099.4\u2009x\u200910<jats:sup>\u22125<\/jats:sup>) and after (OR: 1.28 [1.14\u20131.44], P\u2009=\u20094.70\u2009x\u200910<jats:sup>\u22125<\/jats:sup>) breast cancer diagnosis, are more likely to report a family history of non-BC tumors and have a lower genetic risk score based on common variants for non-BC tumors. In conclusion, interval breast cancer is associated with other tumors and common cancer variants are unlikely to be responsible for this association. These findings could have implications for future screening and prevention programs.<\/jats:p>","DOI":"10.1038\/s41467-019-12652-1","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T10:29:20Z","timestamp":1571826560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Interval breast cancer is associated with other types of tumors"],"prefix":"10.1038","volume":"10","author":[{"given":"Felix","family":"Grassmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marike","family":"Gabrielson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Czene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"12652_CR1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jech.43.2.107","volume":"43","author":"L Tabar","year":"1989","unstructured":"Tabar, L. et al. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J. Epidemiol. Community Health 43, 107\u2013114 (1989).","journal-title":"J. Epidemiol. Community Health"},{"key":"12652_CR2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jama.1995.03520260071035","volume":"273","author":"K Kerlikowske","year":"1995","unstructured":"Kerlikowske, K. et al. Efficacy of screening mammography. A meta-analysis. JAMA 273, 149\u2013154 (1995).","journal-title":"JAMA"},{"key":"12652_CR3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/jnci\/92.9.743","volume":"92","author":"FD Gilliland","year":"2000","unstructured":"Gilliland, F. D. Biologic characteristics of interval and screen-detected breast cancers. J. Natl. Cancer Inst. 92, 743\u2013749 (2000).","journal-title":"J. Natl. Cancer Inst."},{"key":"12652_CR4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/jnci\/84.10.781","volume":"84","author":"L Ma","year":"1992","unstructured":"Ma, L. et al. Case-control study of factors associated with failure to detect breast cancer by mammography. J. Natl. Cancer Inst. 84, 781\u2013785 (1992).","journal-title":"J. Natl. Cancer Inst."},{"key":"12652_CR5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1148\/radiology.199.3.8638010","volume":"199","author":"HC Burrell","year":"1996","unstructured":"Burrell, H. C. et al. Screening interval breast cancers: mammographic features and prognosis factors. Radiology 199, 811\u2013817 (1996).","journal-title":"Radiology"},{"key":"12652_CR6","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-017-0014-x","volume":"3","author":"N Houssami","year":"2017","unstructured":"Houssami, N. & Hunter, K. The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening. npj Breast Cancer 3, 12 (2017).","journal-title":"npj Breast Cancer"},{"key":"12652_CR7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10549-016-3882-0","volume":"158","author":"RJP Weber","year":"2016","unstructured":"Weber, R. J. P. et al. Characteristics and prognosis of interval cancers after biennial screen-film or full-field digital screening mammography. Breast Cancer Res. Treat. 158, 471\u2013483 (2016).","journal-title":"Breast Cancer Res. Treat."},{"key":"12652_CR8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.breast.2015.02.032","volume":"24","author":"B Meshkat","year":"2015","unstructured":"Meshkat, B. et al. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer. Breast 24, 278\u2013282 (2015).","journal-title":"Breast"},{"key":"12652_CR9","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3595","volume":"16","author":"L Domingo","year":"2014","unstructured":"Domingo, L. et al. Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain. Breast Cancer Res. 16, R3 (2014).","journal-title":"Breast Cancer Res."},{"key":"12652_CR10","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-14-558","volume":"14","author":"G Renart-Vicens","year":"2014","unstructured":"Renart-Vicens, G. et al. Evaluation of the interval cancer rate and its determinants on the Girona Health Region\u2019s early breast cancer detection program. BMC Cancer 14, 558 (2014).","journal-title":"BMC Cancer"},{"key":"12652_CR11","doi-asserted-by":"crossref","unstructured":"Caumo, F. et al. Interval cancers in breast cancer screening: comparison of stage and biological characteristics with screen-detected cancers or incident cancers in the absence of screening. Tumori 96, 198\u2013201 (2010).","DOI":"10.1177\/030089161009600203"},{"key":"12652_CR12","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1200\/JCO.2014.58.9986","volume":"33","author":"J Holm","year":"2015","unstructured":"Holm, J. et al. Risk factors and tumor characteristics of interval cancers by mammographic density. J. Clin. Oncol. 33, 1030\u20131037 (2015).","journal-title":"J. Clin. Oncol."},{"key":"12652_CR13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJMoa062790","volume":"356","author":"NF Boyd","year":"2007","unstructured":"Boyd, N. F. et al. Mammographic density and the risk and detection of breast cancer. N. Engl. J. Med. 356, 227\u2013236 (2007).","journal-title":"N. Engl. J. Med."},{"key":"12652_CR14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10552-010-9663-x","volume":"22","author":"JT Lowery","year":"2011","unstructured":"Lowery, J. T. et al. Complementary approaches to assessing risk factors for interval breast cancer. Cancer Causes Control 22, 23\u201331 (2011).","journal-title":"Cancer Causes Control"},{"key":"12652_CR15","doi-asserted-by":"crossref","first-page":"e110207","DOI":"10.1371\/journal.pone.0110207","volume":"9","author":"J Blanch","year":"2014","unstructured":"Blanch, J. et al. Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme. PLoS ONE 9, e110207 (2014).","journal-title":"PLoS ONE"},{"key":"12652_CR16","volume":"16","author":"NF Boyd","year":"2014","unstructured":"Boyd, N. F. et al. Mammographic features associated with interval breast cancers in screening programs. Breast Cancer Res. 16, 417 (2014).","journal-title":"Breast Cancer Res."},{"key":"12652_CR17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/annonc\/mdu565","volume":"26","author":"J Li","year":"2015","unstructured":"Li, J. et al. Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers. Ann. Oncol. 26, 517\u2013522 (2015).","journal-title":"Ann. Oncol."},{"key":"12652_CR18","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1158\/0008-5472.CAN-18-1018","volume":"78","author":"J Li","year":"2018","unstructured":"Li, J. et al. Differential burden of rare and common variants on tumor characteristics, survival, and mode of detection in breast cancer. Cancer Res. 78, 6329\u20136338 (2018).","journal-title":"Cancer Res."},{"key":"12652_CR19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrc1299","volume":"4","author":"PA Futreal","year":"2004","unstructured":"Futreal, P. A. et al. A census of human cancer genes. Nat. Rev. Cancer 4, 177 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"12652_CR20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1200\/JCO.2015.63.0624","volume":"34","author":"J Holm","year":"2016","unstructured":"Holm, J. et al. Associations of breast cancer risk prediction tools with tumor characteristics and metastasis. J. Clin. Oncol. 34, 251\u2013258 (2016).","journal-title":"J. Clin. Oncol."},{"key":"12652_CR21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","volume":"173","author":"K Huang","year":"2018","unstructured":"Huang, K. et al. Pathogenic germline variants in 10,389 adult cancers. Cell 173, 355\u2013370.e14 (2018).","journal-title":"Cell"},{"key":"12652_CR22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.gde.2014.04.002","volume":"26","author":"J Vijg","year":"2014","unstructured":"Vijg, J. Somatic mutations, genome mosaicism, cancer and aging. Curr. Opin. Genet Dev. 26, 141\u2013149 (2014).","journal-title":"Curr. Opin. Genet Dev."},{"key":"12652_CR23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10555-013-9429-5","volume":"32","author":"L Pikor","year":"2013","unstructured":"Pikor, L. et al. The detection and implication of genome instability in cancer. Cancer Metastasis Rev. 32, 341\u2013352 (2013).","journal-title":"Cancer Metastasis Rev."},{"key":"12652_CR24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","volume":"173","author":"F Sanchez-Vega","year":"2018","unstructured":"Sanchez-Vega, F. et al. Oncogenic signaling pathways in The Cancer Genome Atlas. Cell 173, 321\u2013337.e10 (2018).","journal-title":"Cell"},{"key":"12652_CR25","doi-asserted-by":"crossref","unstructured":"Coleman, W. B. Chapter 4 - Neoplasia, in Coleman WB, Tsongalis GJBT-MP (Second E (eds). Academic Press, 2018, pp 71\u201397.","DOI":"10.1016\/B978-0-12-802761-5.00004-3"},{"key":"12652_CR26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000455999","volume":"12","author":"E Hahnen","year":"2017","unstructured":"Hahnen, E. et al. Germline mutations in triple-negative breast cancer. Breast Care (Basel) 12, 15\u201319 (2017).","journal-title":"Breast Care (Basel)"},{"key":"12652_CR27","volume":"13","author":"D Yi","year":"2019","unstructured":"Yi, D. et al. Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study. Hum. Genomics 13, 4 (2019).","journal-title":"Hum. Genomics"},{"key":"12652_CR28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semcancer.2014.04.002","volume":"30","author":"E Wang","year":"2015","unstructured":"Wang, E. et al. Predictive genomics: sa cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. Semin Cancer Biol. 30, 4\u201312 (2015).","journal-title":"Semin Cancer Biol."},{"key":"12652_CR29","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1158\/2159-8290.CD-15-1227","volume":"6","author":"SP Kar","year":"2016","unstructured":"Kar, S. P. et al. Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types. Cancer Discov. 6, 1052\u20131067 (2016).","journal-title":"Cancer Discov."},{"key":"12652_CR30","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat, N. et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J. Natl Cancer Inst. 105, 812\u2013822 (2013).","journal-title":"J. Natl. Cancer Inst."},{"key":"12652_CR31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc.2016.72","volume":"16","author":"FC Nielsen","year":"2016","unstructured":"Nielsen, F. C., van Overeem Hansen, T. & S\u00f8rensen, C. S. Hereditary breast and ovarian cancer: new genes in confined pathways. Nat. Rev. Cancer 16, 599\u2013612 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"12652_CR32","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4319-4","volume":"18","author":"G Defossez","year":"2018","unstructured":"Defossez, G., Quillet, A. & Ingrand, P. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers. BMC Cancer 18, 393 (2018).","journal-title":"BMC Cancer"},{"key":"12652_CR33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12253-008-9010-7","volume":"14","author":"I P\u00e1lka","year":"2008","unstructured":"P\u00e1lka, I. et al. Tumor characteristics in screen-detected and symptomatic breast cancers. Pathol. Oncol. Res. 14, 161\u2013167 (2008).","journal-title":"Pathol. Oncol. Res."},{"key":"12652_CR34","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.seminoncol.2003.08.022","volume":"30","author":"SMA Matesich","year":"2003","unstructured":"Matesich, S. M. A. & Shapiro, C. L. Second cancers after breast cancer treatment. Semin Oncol. 30, 740\u2013748 (2003).","journal-title":"Semin Oncol."},{"key":"12652_CR35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3892\/mco.2014.250","volume":"2","author":"C Dong","year":"2014","unstructured":"Dong, C. & Chen, L. Second malignancies after breast cancer: the impact of adjuvant therapy. Mol. Clin. Oncol. 2, 331\u2013336 (2014).","journal-title":"Mol. Clin. Oncol."},{"key":"12652_CR36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ygyno.2014.10.029","volume":"136","author":"E Molina-Montes","year":"2015","unstructured":"Molina-Montes, E. et al. Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis. Gynecol. Oncol. 136, 158\u2013171 (2015).","journal-title":"Gynecol. Oncol."},{"key":"12652_CR37","unstructured":"Hemminki, K. & Boffetta, P. Multiple primary cancers as clues to environmental and heritable causes of cancer and mechanisms of carcinogenesis. IARC Sci. Publ. 289\u2013297 (2004)."},{"key":"12652_CR38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng.2563","volume":"45","author":"K Michailidou","year":"2013","unstructured":"Michailidou, K. et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. 45, 353\u2013361 (2013). 361e1\u20132.","journal-title":"Nat. Genet."},{"key":"12652_CR39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1148\/radiol.12102348","volume":"266","author":"JI Payne","year":"2013","unstructured":"Payne, J. I. et al. A Review of Interval Breast Cancers Diagnosed among Participants of the Nova Scotia Breast Screening Program. Radiology 266, 96\u2013103 (2013).","journal-title":"Radiology"},{"key":"12652_CR40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1148\/radiol.2017162159","volume":"287","author":"S Hofvind","year":"2018","unstructured":"Hofvind, S. et al. Interval breast cancer rates and histopathologic tumor characteristics after false-positive findings at mammography in a population-based screening program. Radiology 287, 58\u201367 (2018).","journal-title":"Radiology"},{"key":"12652_CR41","volume":"17","author":"RMG van Bommel","year":"2017","unstructured":"van Bommel, R. M. G. et al. Interval breast cancer characteristics before, during and after the transition from screen-film to full-field digital screening mammography. BMC Cancer 17, 315 (2017).","journal-title":"BMC Cancer"},{"key":"12652_CR42","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-015-0591-2","volume":"17","author":"JS Brand","year":"2015","unstructured":"Brand, J. S. et al. Identification of two novel mammographic density loci at 6Q25.1. Breast Cancer Res. 17, 75 (2015).","journal-title":"Breast Cancer Res."},{"key":"12652_CR43","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/ije\/dyw357","volume":"46","author":"M Gabrielson","year":"2017","unstructured":"Gabrielson, M. et al. Cohort profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA). Int J. Epidemiol. 46, 1740\u20131741g (2017).","journal-title":"Int J. Epidemiol."},{"key":"12652_CR44","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1047-2797(03)00042-5","volume":"13","author":"J Hays","year":"2003","unstructured":"Hays, J. et al. The Women\u2019s Health Initiative recruitment methods and results. Ann. Epidemiol. 13, S18\u2013S77 (2003).","journal-title":"Ann. Epidemiol."},{"key":"12652_CR45","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S1047-2797(03)00043-7","volume":"13","author":"GL Anderson","year":"2003","unstructured":"Anderson, G. L. et al. Implementation of the Women\u2019s Health Initiative study design. Ann. Epidemiol. 13, S5\u2013S17 (2003).","journal-title":"Ann. Epidemiol."},{"key":"12652_CR46","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-017-0820-y","volume":"19","author":"M Eriksson","year":"2017","unstructured":"Eriksson, M. et al. A clinical model for identifying the short-term risk of breast cancer. Breast Cancer Res. 19, 29 (2017).","journal-title":"Breast Cancer Res."},{"key":"12652_CR47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10549-018-4690-5","volume":"169","author":"M Eriksson","year":"2018","unstructured":"Eriksson, M. et al. A comprehensive tool for measuring mammographic density changes over time. Breast Cancer Res. Treat. 169, 371\u2013379 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"12652_CR48","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-14-272","volume":"14","author":"A Coyte","year":"2014","unstructured":"Coyte, A., Morrison, D. S. & McLoone, P. Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study. BMC Cancer 14, 272 (2014).","journal-title":"BMC Cancer"},{"key":"12652_CR49","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1158\/1055-9965.EPI-16-0106","volume":"26","author":"CI Amos","year":"2017","unstructured":"Amos, C. I. et al. The OncoArray Consortium: a network for understanding the genetic architecture of common cancers. Cancer Epidemiol. Biomark. Prev. 26, 126\u2013135 (2017).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"12652_CR50","doi-asserted-by":"crossref","first-page":"e1004234","DOI":"10.1371\/journal.pgen.1004234","volume":"10","author":"J O\u2019Connell","year":"2014","unstructured":"O\u2019Connell, J. et al. A general approach for haplotype phasing across the full spectrum of relatedness. PLoS Genet. 10, e1004234 (2014).","journal-title":"PLoS Genet."},{"key":"12652_CR51","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajhg.2012.06.013","volume":"91","author":"AL Williams","year":"2012","unstructured":"Williams, A. L. et al. Phasing of many thousands of genotyped samples. Am. J. Hum. Genet. 91, 238\u2013251 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"12652_CR52","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1210\/jc.2016-2936","volume":"102","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Gene-hormone therapy interaction and fracture risk in postmenopausal women. J. Clin. Endocrinol. Metab. 102, 1908\u20131916 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"12652_CR53","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.2354","volume":"44","author":"B Howie","year":"2012","unstructured":"Howie, B. et al. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955\u2013959 (2012).","journal-title":"Nat. Genet."},{"key":"12652_CR54","unstructured":"R Development Core Team & R Core Team. R: A Language and Environment for Statistical Computing (2010)."},{"key":"12652_CR55","doi-asserted-by":"crossref","first-page":"e1002138","DOI":"10.1371\/journal.pgen.1002138","volume":"7","author":"L Dumitrescu","year":"2011","unstructured":"Dumitrescu, L. et al. Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study. PLoS Genet. 7, e1002138 (2011).","journal-title":"PLoS Genet."},{"key":"12652_CR56","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284\u20131287 (2016).","journal-title":"Nat. Genet."},{"key":"12652_CR57","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/bioinformatics\/btr509","volume":"27","author":"H Li","year":"2011","unstructured":"Li, H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics 27, 2987\u20132993 (2011).","journal-title":"Bioinformatics"},{"key":"12652_CR58","doi-asserted-by":"crossref","first-page":"e37979","DOI":"10.1371\/journal.pone.0037979","volume":"7","author":"F Grassmann","year":"2012","unstructured":"Grassmann, F. et al. Modelling the genetic risk in age-related macular degeneration. PLoS ONE 7, e37979 (2012).","journal-title":"PLoS ONE"},{"key":"12652_CR59","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-017-0418-0","volume":"9","author":"F Grassmann","year":"2017","unstructured":"Grassmann, F. et al. Genetic pleiotropy between age-related macular degeneration and 16 complex diseases and traits. Genome Med. 9, 29 (2017).","journal-title":"Genome Med."},{"key":"12652_CR60","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature24284","volume":"551","author":"K Michailidou","year":"2017","unstructured":"Michailidou, K. et al. Association analysis identifies 65 new breast cancer risk loci. Nature 551, 92\u201394 (2017).","journal-title":"Nature"},{"key":"12652_CR61","doi-asserted-by":"crossref","first-page":"D896","DOI":"10.1093\/nar\/gkw1133","volume":"45","author":"J MacArthur","year":"2017","unstructured":"MacArthur, J. et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res. 45, D896\u2013D901 (2017).","journal-title":"Nucleic Acids Res"},{"key":"12652_CR62","unstructured":"Therneau T. M. A Package for Survival Analysis in S (2015)."},{"key":"12652_CR63","unstructured":"Kassambara A. & Kosinski M. survminer: Drawing Survival Curves using \u201cggplot2\u201d (2018)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12652-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12652-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12652-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T01:31:44Z","timestamp":1671240704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12652-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["12652"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-12652-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"11 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4648"}}